Objective response rate assessment in oncology: Current situation and future expectations
Best Overall Response Rate (full analysis population) | Download Table
Efficacy | BALVERSA® (erdafitinib) HCP
Cell therapy doubles survival, response rates in advanced melanoma
BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC
Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma | Semantic Scholar
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial | Nature Medicine
Overall Response Rates - WM | IMBRUVICA® (ibrutinib) HCP
ODOMZO® (sonidegib) | Efficacy Data
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children | NEJM
Efficacy | Tivdak® (tisotumab vedotin-tftv)
Efficacy Data | KYMRIAH® (tisagenlecleucel) for DLBCL | HCP
Zacks Small Cap Research - ONCS: New Data Provide Evidence that ImmunoPulse IL-12 Can Prime the Immune System
Durable Response Rate
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Visualization of efficacy endpoints in oncology clinical trials
Overall response rate | Download Table
Durable Response Rate
Overall Response Rate in Previously Untreated CLL | CALQUENCE® (acalabrutinib) 100 mg tablets | For HCPs
RESONATE-2 - Overall Response Rate | IMBRUVICA® (ibrutinib) HCP
The overall response rate | Download Table
Response rates Overall response rate and depth of response according to... | Download Scientific Diagram
COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Objective Response Rate
What Low Response Rates Mean for Telephone Surveys | Pew Research Center
